OMRON Corporation
Notice Regarding Company Split (Absorption-type Split) of Device & Module Solutions Business and Share Transfer of the Successor Company (Change of Subsidiaries)
OMRON Corporation will transfer its Device & Module Solutions business to a successor company through an absorption-type split effective July 1, 2026, and plans to transfer all shares of the successor company to TCG2602 Co., Ltd. on October 1, 2026.
Key Figures
- Net Sales of Divided Segment: 68,843 million yen (Fiscal Year Ending March 2025)
- Transferred Business Value: 81,000 million yen
- Effective Date of Absorption-type Split: 2026-07-01 (Scheduled)
- Execution Date of Share Transfer: 2026-10-01 (Scheduled)
- Capital of Successor Company: 10 million yen
- Capital of Dividing Company: 64,100 million yen
AI要約
Overview of Company Split and Share Transfer
OMRON Corporation will spin off its Device & Module Solutions business (Electronic Components segment) by transferring the business to the successor company, OMRON Device Corporation, via an absorption-type split effective July 1, 2026. Subsequently, on October 1, 2026, it plans to transfer all shares of the successor company to TCG2602 Co., Ltd., a company established by The Carlyle Group. This restructuring within the OMRON Group aims to strengthen collaboration with external partners and accelerate business speed.
Schedule and Impact
The absorption-type split is scheduled to take effect on July 1, 2026, with the share transfer execution date planned for October 1, 2026. After the transfer, OMRON will invest to hold a 5% equity stake in TCG2601 Co., Ltd., maintaining collaboration with the successor company and group companies while supporting the growth of the independent company. The transferred business reported net sales of 68.843 billion yen for the fiscal year ending March 2025, and the business transfer value is 81.0 billion yen.
OMRON Corporation
Company overview · Stock price · Financial data · All IR
